ID   Karpas-707H
AC   CVCL_9552
SY   Karpas 707H; KARPAS 707H
DR   Wikidata; Q54899504
DR   Ximbio; 152424
RX   PubMed=11172031;
RX   PubMed=11839246;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Produces Ig lambda.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Derived from sampling site: Bone marrow.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0010 ! Karpas-707
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 12-01-21; Version: 13
//
RX   PubMed=11172031; DOI=10.1073/pnas.98.4.1799;
RA   Karpas A., Dremucheva A., Czepulkowski B.H.;
RT   "A human myeloma cell line suitable for the generation of human
RT   monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:1799-1804(2001).
//
RX   PubMed=11839246; DOI=10.1089/15368590152740680;
RA   Vaisbourd M., Ignatovich O., Dremucheva A., Karpas A., Winter G.;
RT   "Molecular characterization of human monoclonal antibodies derived
RT   from fusions of tonsil lymphocytes with a human myeloma cell line.";
RL   Hybrid. Hybridomics 20:287-292(2001).
//